HCID 86703773, compound → HCID 86703774, compound
Reaction equation
[CH:1]([N:14]1[CH2:17][CH:16]([O:18][C:19]2[C:31]([CH:32]3[CH2:34][CH2:33]3)=[CH:30][C:22]([C:23]([O:25]C(C)(C)C)=[O:24])=[C:21]([F:35])[CH:20]=2)[CH2:15]1)([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C(Cl)Cl.FC(F)(F)C(O)=O>[CH:1]([N:14]1[CH2:15][CH:16]([O:18][C:19]2[C:31]([CH:32]3[CH2:33][CH2:34]3)=[CH:30][C:22]([C:23]([OH:25])=[O:24])=[C:21]([F:35])[CH:20]=2)[CH2:17]1)([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of tert-butyl 4-(1-benzhydrylazetidin-3-yloxy)-5-cyclopropyl-2-fluorobenzoate (650 mg, 1.37 mmol) in DCM (10 mL) and trifluoroacetic acid (5 mL) was stirred at room temperature for 2 h. The solvent was removed and the residue was used in the next step without further purification.
Workup
- customThe solvent was removed
- customthe residue was used in the next step without further purification
Sources & evidence
- ORD record
- ord-256d3e420ce244a492e47ee142c42dba
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08952169B2
Reaction notes
Loading…